维普期刊资源整合服务平台（V6.5）

124篇 您的检索式：作者名="Balakumar P"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Arsenic exposure and cardiovascular disorders : an overview 显示文摘	Balakumar P Kaur J	2009	Cardiovasc Toxicol2009，9，4：	1
2	Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared? 显示文摘	Balakumar P Jagadeesh G	2010	Pharmacol Res2010，62，5：	1
3	Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions 显示文摘	Balakumar P Kaur T Singh M	2008	Toxicology2008，245，12：	1
4	Vascular endothelial dysfunction: a tug of war in diabetic nephropa- thy? 显示文摘	Balakumar P Chakkarwar VA Krishan P	2009	Biomed Pharmacother2009，63，：	1
5	Multifarious molecular signaling cascades of cardiac hypertrophy:can the muddy waters be cleared?显示文摘	Balakumar P Jagadeesh G	2010	Pharmacol Res2010，62，5：	1
6	Pathophysiology of diabetic nephropathy:involvement of multifaceted signaling mechanism显示文摘	Balakumar P Arora MK Reddy J	2009	J Cardiovasc Pharmacol2009，54，2：	1
7	Telmisartan in the management of diabetic nephropathy:a contemporary view显示文摘	Balakumar P Bishnoi HK Mahadevan N	2012	Curr Diabetes Rev2012，8，3：	1
8	Modulation of cardiopro- tective effect of ischemic pre - and postconditioning in the hyperho- mocysteinemic rat heart 显示文摘	Balakumar P Rohilla A Singh G	2009	Methods Find Exp Clin Pharmacol2009，31，2：	1
9	Emerging role of PPAR lig- ands in the management of diabetic nephropathy显示文摘	Balakumar P Arora MK Singh M	2009	Pharmacol Res2009，60，3：	1
10	Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats 显示文摘	Singh AP Singh M Balakumar P	2008	J Cardiovasc Pharmacol2008，51，6：	1
11	Pathophysiology of diabetic nephropathy:involvement of multifaceted signaling mechanism显示文摘	Balakumar P Arora MK Reddy J		0，，02：	1
12	Ameliorative effect of combina-tion of benfotiamine and fenofibrate in diabetes-induced vascular endo-thelial dysfunction and nephropathy in the rat显示文摘	Balakumar P Chakkarwar VA Singh M		0，，1：	1
13	Effect of mast cell sta- bilizers in hyperhomocysteinemia - induced cardiac hypertrophy in rats显示文摘	SINGH A P SINGH M BALAKUMAR P	2008	J Cardiovasc Pharmaeol2008，51，6：	1
14	Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders显示文摘	BALAKUMAR P KAUR J	2009	Pharmacol Res2009，60，5：	1
15	Pathophysi-ology of diabeticnephropathy : involvement of multi-faceted signaling mechanism 显示文摘	Balakumar P Arora MK Reddy J	2009	Journal of Cardio-vascular Pharmacology2009，12，：	1
16	Vascular endothelial dysfunction:a tug of war in diabetic nephropathy显示文摘	Balakumar P Chakkarwar V A Krishan P	2009	Biomedicine&Pharmacotherapy2009，63，3：	1
17	Experimental models for nephropathy 显示文摘	Balakumar P Chakkarwar V A Kumar V	2008	J Renin Angiotensin Aldosterone Syst2008，9，4：	1
18	Emerging role of PPAR ligands in the management of diabetic nephropathy 显示文摘	Balakumar P Arora MK Singh M	2009	Pharmacol Res2009，60，3：	1
19	Pathophysiology of diabet- ic nephropathy: involvement of multifaeeted signalling mechanism显示文摘	Balakumar P Arora MK Reddy J	2009	Cardiovasc Pharmaeol2009，2，54：	1
20	Amelinrative effct of com- bination of benfotiamine and fenofibrate in diabetes -induced vas- cular endothelial dysfunction and nephropathy in the rat 显示文摘	Balakumar P Chakkarwar VA Singh M	2009	Mol Cell Biochem2009，320，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示